Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and by the end of 2017, revenue from the device grew +493% vs. the previous year.
Sources: Life Spine; ORTHOWORLD Inc.
Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and...
Life Spine announced 1Q18 ProLift® expandable spacer revenue growth of +93% vs. 1Q17.
The Micro-Invasive titanium device for TLIF and PLIF procedures supports in situ expansion to restore anatomic disc height and decompress neural elements.
ProLift was cleared for U.S. marketing in 1Q16. Limited launch followed in the next quarter, and by the end of 2017, revenue from the device grew +493% vs. the previous year.
Sources: Life Spine; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.